Education
About Us
Working with TipRanks
Follow Us
Immucell Corp. (ICCC)
NASDAQ:ICCC
Total Valuation
Immucell has a market cap or net worth of $54.82M. The enterprise value is $71.12M.
Market Cap$54.82M
Enterprise Value$71.12M
Share Statistics
Immucell has 9,045,851 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,045,851
Owned by Insiders1.58%
Owned by Institutions3.62%
Financial Efficiency
Immucell’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -3.87%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-3.87%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee383.96K
Profits Per Employee-31.26K
Employee Count69
Asset Turnover0.59
Inventory Turnover2.61
Valuation Ratios
The current PE Ratio of Immucell is 32.1. Immucell’s PEG ratio is ―.
PE Ratio32.1
PS Ratio―
PB Ratio―
Price to Fair Value1.53
Price to FCF―
Price to Operating Cash Flow22.03
PEG Ratio―
Income Statement
In the last 12 months, Immucell had revenue of 26.49M and earned -2.16M in profits. Earnings per share was -0.26.
Revenue26.49M
Gross Profit7.94M
Operating Income-1.64M
Pretax Income-2.15M
Net Income-2.16M
EBITDA1.11M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was 2.53M and capital expenditures -768.84K, giving a free cash flow of 1.76M billion.
Operating Cash Flow2.53M
Free Cash Flow1.76M
Free Cash Flow per Share0.20
Dividends & Yields
Immucell pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.18
52-Week Price Change69.86%
50-Day Moving Average6.28
200-Day Moving Average5.69
Relative Strength Index (RSI)47.35
Average Volume (3m)8.22K
Important Dates
Immucell upcoming earnings date is Nov 17, 2025, After Close (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Immucell as a current ratio of 3.41, with Debt / Equity ratio of 47.76%
Current Ratio3.41
Quick Ratio1.80
Debt to Market Cap0.25
Net Debt to EBITDA10.22
Interest Coverage Ratio-2.88
Taxes
In the past 12 months, Immucell has paid 10.06K in taxes.
Income Tax10.06K
Effective Tax Rate>-0.01
Enterprise Valuation
Immucell EV to EBITDA ratio is 48.14, with an EV/FCF ratio of -495.28.
EV to Sales2.02
EV to EBITDA48.14
EV to Free Cash Flow-495.28
EV to Operating Cash Flow149.21
Balance Sheet
Immucell has $6.00M in cash and marketable securities with $14.27M in debt, giving a net cash position of -$8.27M billion.
Cash & Marketable Securities$6.00M
Total Debt$14.27M
Net Cash-$8.27M
Net Cash Per Share-$0.91
Tangible Book Value Per Share$3.36
Margins
Gross margin is 41.56%, with operating margin of -6.19%, and net profit margin of -8.14%.
Gross Margin41.56%
Operating Margin-6.19%
Pretax Margin-8.10%
Net Profit Margin-8.14%
EBITDA Margin4.19%
EBIT Margin-5.96%
Analyst Forecast
The average price target for Immucell is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside-0.50% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast21.75%
EPS Growth Forecast―